Our health-care roundtable gathers The Motley Fool's top health-care analysts to discuss the sector's biggest stories in a free flowing and highly opinionated format.

In this portion of the video, the guys speculate on what Johnson & Johnson (NYSE:JNJ) should be doing for shareholders, and why the company's lack of interest in share buybacks now might be a reason Warren Buffett's Berkshire Hathaway (NYSE:BRK-A) walked away.

Brenton Flynn and David Williamson have no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.